YSB (9885) Stock Overview
Develops digital pharmaceutical platform for pharmaceutical companies, distributors, vendors, pharmacies, and primary healthcare institutions in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
9885 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
YSB Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$12.40 |
| 52 Week High | HK$11.94 |
| 52 Week Low | HK$5.18 |
| Beta | 1.28 |
| 1 Month Change | 31.22% |
| 3 Month Change | 33.05% |
| 1 Year Change | 72.94% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -41.23% |
Recent News & Updates
Recent updates
The Market Lifts YSB Inc. (HKG:9885) Shares 32% But It Can Do More
Jun 22
Even With A 31% Surge, Cautious Investors Are Not Rewarding YSB Inc.'s (HKG:9885) Performance Completely
May 07We Think That There Are Issues Underlying YSB's (HKG:9885) Earnings
May 02Health Check: How Prudently Does YSB (HKG:9885) Use Debt?
May 22Shareholder Returns
| 9885 | HK Healthcare | HK Market | |
|---|---|---|---|
| 7D | 13.6% | 1.8% | 0.3% |
| 1Y | 72.9% | -14.0% | 28.7% |
Return vs Industry: 9885 exceeded the Hong Kong Healthcare industry which returned -14% over the past year.
Return vs Market: 9885 exceeded the Hong Kong Market which returned 28.7% over the past year.
Price Volatility
| 9885 volatility | |
|---|---|
| 9885 Average Weekly Movement | 8.1% |
| Healthcare Industry Average Movement | 6.9% |
| Market Average Movement | 7.3% |
| 10% most volatile stocks in HK Market | 15.9% |
| 10% least volatile stocks in HK Market | 3.4% |
Stable Share Price: 9885 has not had significant price volatility in the past 3 months compared to the Hong Kong market.
Volatility Over Time: 9885's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2015 | 6,620 | Buzhen Zhang | www.ysbang.cn |
YSB Inc. develops digital pharmaceutical platform for pharmaceutical companies, distributors, vendors, pharmacies, and primary healthcare institutions in China. The company offers ClouMinihouse, a primary smart healthcare system that include Future Lou, a series of advanced point-of-care testing and monitoring devices; Cloud consultation SaaS, a digital clinic management system; and ClouWiseDoctor, a smart AI doctors-aid system. It also provides SaaS solutions; and YSB eLearn that provides online courses for the preparation of the pharmacist qualification examinations.
YSB Inc. Fundamentals Summary
| 9885 fundamental statistics | |
|---|---|
| Market cap | HK$8.07b |
| Earnings (TTM) | HK$94.32m |
| Revenue (TTM) | HK$20.69b |
Is 9885 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 9885 income statement (TTM) | |
|---|---|
| Revenue | CN¥18.93b |
| Cost of Revenue | CN¥16.90b |
| Gross Profit | CN¥2.04b |
| Other Expenses | CN¥1.95b |
| Earnings | CN¥86.31m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.13 |
| Gross Margin | 10.76% |
| Net Profit Margin | 0.46% |
| Debt/Equity Ratio | 4.3% |
How did 9885 perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/08 09:20 |
| End of Day Share Price | 2025/10/08 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
YSB Inc. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | CMB International Securities Limited |
| Zhen Li | Tianfeng Securities Brokerage Co., Ltd |